Hematology/oncology pharmacists serve a pivotal and specialized role related to biologic therapies (including biosimilars), which demands a high level of expertise that informs day to day practice, consultation with clinicians, patients, and health system/formulary committees. This program is designed to equip hematology/oncology pharmacists with evidence-based knowledge and increased competence regarding the safety and efficacy of biosimilars; enabling participants to confidently apply this information effectively into the multiple facets of pharmacy practice.